Dingfeng Jiang
Overview
Explore the profile of Dingfeng Jiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shadman M, Manzoor B, Sail K, Tuncer H, Allan J, Ujjani C, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Apr;
23(7):515-526.
PMID: 37076367
Introduction: This study assessed treatment discontinuation patterns and reasons among chronic lymphocytic leukemia (CLL) patients initiating first-line (1L) and second-line (2L) treatments in real-world settings. Materials And Methods: Using deidentified...
2.
Sharman J, Biondo J, Boyer M, Fischer K, Hallek M, Jiang D, et al.
EJHaem
. 2022 Jul;
3(2):492-506.
PMID: 35846043
We reviewed the literature (January 2010-June 2021) on the effectiveness of debulking strategies before venetoclax initiation in patients with chronic lymphocytic leukemia to reduce tumor burden, downgrade tumor lysis syndrome...
3.
Davids M, Shadman M, Parikh S, Ujjani C, Crombie J, Jiang D, et al.
Am J Hematol
. 2021 Dec;
97(3):E105-E109.
PMID: 34929063
No abstract available.
4.
Nguyen V, Jiang D, Hoffman S, Guntaka S, Mays J, Wang A, et al.
Inflamm Bowel Dis
. 2017 Sep;
23(10):1825-1831.
PMID: 28885229
Background: The impact of diagnostic delay in inflammatory bowel disease, including Crohn's disease (CD) and ulcerative colitis (UC), on disease course remains uncertain. This study examines factors that may influence...
5.
Lopez-Bastida J, Lopez-Siguero J, Oliva-Moreno J, Perez-Nieves M, Villoro R, Dilla T, et al.
Diabetes Res Clin Pract
. 2017 Mar;
127:59-69.
PMID: 28319803
Aims: To estimate the social-economic costs of Type 1 Diabetes Mellitus (T1DM) in patients aged 0-17years in Spain from a social perspective. Methods: We conducted a cross-sectional observational study in...
6.
Peng X, Jiang D, Liu D, Varnado O, Bae J
Patient Prefer Adherence
. 2016 Aug;
10:1539-46.
PMID: 27570448
Background: Metformin is an oral antidiabetic drug (OAD) widely used as first-line therapy in type 2 diabetes (T2D) treatments. Numerous treatment pathways after metformin failure exist. It is important to...
7.
Linetzky B, Jiang D, Funnell M, Curtis B, Polonsky W
J Diabetes
. 2016 Jul;
9(6):596-605.
PMID: 27368146
Background: The 2-year prospective MOSAIc (Multinational Observational Study assessing Insulin use: understanding the challenges associated with progression of therapy) study is investigating whether patient-, physician-, and health system-related factors affect...
8.
Matsuba I, Sawa T, Kawata T, Kanamori A, Jiang D, Machimura H, et al.
Diabetes Ther
. 2016 Jun;
7(2):349-60.
PMID: 27255328
Introduction: Guidelines recommend insulin progression for patients with type 2 diabetes (T2D) with inadequate glycemic control. The Multinational Observational Study Assessing Insulin use (MOSAIc [ClinicalTrials.gov identifier, NCT01400971]) study is a...
9.
Polinski J, Kim S, Jiang D, Hassoun A, Shrank W, Cos X, et al.
BMC Endocr Disord
. 2015 Sep;
15:46.
PMID: 26353820
Background: Among patients with type 2 diabetes, insulin intensification to achieve glycemic targets occurs less often than clinically indicated. Barriers to intensification are not well understood. We present patients' baseline...
10.
Ascher-Svanum H, Zagar A, Jiang D, Schuster D, Schmitt H, Dennehy E, et al.
Diabetes Ther
. 2015 Jul;
6(3):403.
PMID: 26223205
No abstract available.